BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38762739)

  • 1. Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients.
    Gao X; Jin X; Huang R; Li Z; Zhang H; Fan P
    BMC Surg; 2024 May; 24(1):162. PubMed ID: 38762739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
    Bawa H; Weick JW; Dirschl DR; Luu HH
    J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Fondaparinux Versus Nadroparin Calcium Thromboprophylaxis on Clinical Parameters Following Total Knee Arthroplasty.
    Mihaljević Z; Dimnjaković D; Tripković B; Buljan M; Aljinović A; Delimar D; Bićanić G
    Acta Clin Croat; 2016 Sep; 55(3):414-421. PubMed ID: 29045105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
    Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
    Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic effect of fondaparinux and enoxaparin for preventing pulmonary embolism after total hip or knee arthroplasty: A retrospective observational study using the Japanese Diagnosis Procedure Combination database.
    Shoda N; Yasunaga H; Horiguchi H; Fushimi K; Matsuda S; Kadono Y; Tanaka S
    Mod Rheumatol; 2015 Jul; 25(4):625-9. PubMed ID: 25529031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below-knee plaster cast (PROTECT): A randomised controlled trial.
    Bruntink MM; Groutars YME; Schipper IB; Breederveld RS; Tuinebreijer WE; Derksen RJ;
    Injury; 2017 Apr; 48(4):936-940. PubMed ID: 28279428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
    Liu J; Zhao J; Yan Y; Su J
    Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis.
    Wang L; Xu Z; Zhang L
    J Musculoskelet Neuronal Interact; 2024 Jun; 24(2):185-191. PubMed ID: 38826001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study.
    van der Veen L; Segers M; van Raay JJ; Gerritsma-Bleeker CL; Brouwer RW; Veeger NJ; van Hulst M
    BMJ Open; 2021 Jan; 11(1):e040336. PubMed ID: 33462096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Anaemia Is a Risk Factor for Bleeding-Related Event in Thromboprophylaxis Using Fondaparinux Sodium Injection after Total Knee or Hip Arthroplasty.
    Enokiya T; Hasegawa M; Morikawa Y; Muraki Y; Sudo A; Okuda M
    Biol Pharm Bull; 2020; 43(2):266-271. PubMed ID: 32009116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
    Yamaguchi T; Hasegawa M; Niimi R; Sudo A
    Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
    ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
    JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
    Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
    Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
    Sasaki H; Ishida K; Shibanuma N; Tei K; Tateishi H; Toda A; Yamashiro Y; Matsumoto T; Kuroda R; Kurosaka M
    Int Orthop; 2014 Mar; 38(3):525-9. PubMed ID: 24100922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty].
    Enokiya T; Muraki Y; Iwamoto T; Kawase R; Hasegawa M; Sudo A; Uchida A; Okuda M
    Yakugaku Zasshi; 2012; 132(5):683-7. PubMed ID: 22687701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep vein thrombosis after total hip arthroplasty and total knee arthroplasty in patients with previous ischemic stroke.
    Qin J; Xu Z; Shi D; Chen D; Dai J; Teng H; Jiang Q
    Int J Low Extrem Wounds; 2013 Dec; 12(4):316-9. PubMed ID: 24043672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer.
    Niimi R; Hasegawa M; Shi DQ; Sudo A
    Thromb Res; 2012 Nov; 130(5):759-64. PubMed ID: 22192153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of 11 anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and network meta-analysis.
    Huang Z; Xu X; Xu D; Zhao P; Zou M
    Medicine (Baltimore); 2023 Jan; 102(2):e32635. PubMed ID: 36637921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism is rare after total hip and knee joint arthroplasty with long thromboprophylaxis in Finnish fast-track hospitals.
    Moisander AM; Pamilo K; Eskelinen A; Huopio J; Kautiainen H; Kuitunen A; Paloneva J
    Arch Orthop Trauma Surg; 2023 Sep; 143(9):5623-5629. PubMed ID: 37067559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.